MGLIX | RRGRX | MGLIX / RRGRX | |
Total Expense Ratio | 0.94 | 0.79 | 119% |
Annual Report Gross Expense Ratio | 0.95 | 0.95 | 100% |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 2.494 | 5.000 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 160M | 1,427% |
Annual Yield % from dividends | 2.53 | 2.99 | 85% |
Returns for 1 year | 3.42 | 9.76 | 35% |
Returns for 3 years | -9.29 | 0.10 | -9,181% |
Returns for 5 years | 11.20 | 8.51 | 132% |
Returns for 10 years | 32.20 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MAGCX | 27.90 | N/A | N/A |
BlackRock Advantage Global Institutional | |||
JFNAX | 63.85 | N/A | N/A |
Janus Henderson Global Life Sciences A | |||
UIVAX | 18.90 | N/A | N/A |
Victory Value Institutional | |||
AMIDX | 13.31 | N/A | N/A |
Amana Developing World Institutional | |||
RYAZX | 183.24 | N/A | N/A |
Rydex S&P SmallCap 600 Pure Value H |